Trials / Unknown
UnknownNCT03872648
TransCare - Genital Surgery for Trans Women in Centralized vs. Decentralized Health Care Delivery Settings
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 64 (estimated)
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf · Academic / Other
- Sex
- Male
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
Trans (i.e., transgender, transsexual) individuals experience a gender that does not match their sex assigned at birth (Gender Incongruence), which can lead to distress called gender dysphoria (formerly known as transsexualism). Trans health care (THC) is primarily focusing on transition-related medical interventions (e.g. genital surgery) to reduce gender dysphoria and improve the quality of life. To date, trans individuals access THC services in both decentralized (e.g., various transition-related interventions are spread over several locations) and centralized structures (e.g., gender affirmative medical treatments are provided by a single source). The TransCare study examines genital surgery for trans women (e.g. penile inversion vaginoplasty), focusing on the effect of different health care delivery settings (e.g., if patients received all treatments from a single source or spread over several locations) on psychosocial outcomes and the quality of healthcare.
Conditions
Timeline
- Start date
- 2019-01-21
- Primary completion
- 2021-06-01
- Completion
- 2021-12-01
- First posted
- 2019-03-13
- Last updated
- 2019-11-07
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03872648. Inclusion in this directory is not an endorsement.